GLP-1 receptor agonist medications for obesity and type 2 diabetes treatment: a rapid review of changes in eating behaviors and eating disorder risk
A comprehensive approach to beauty, recovery, and anti-aging that works from the cellular level up
While evidence supporting specific multi-hormone combinations is limited, this approach is widely used in clinical practice when single-agent commercial products would require the patient to use multiple separate products
complement inhibitor / Rare kidney diseasesIgA nephropathyPhase 2 plannedbasket trial planned 2H 2026Lupus nephritisPhase 2 plannedbasket trial planned 2H 2026C3 glomerulopathyPhase 2 plannedbasket trial planned 2H 2026 AKB-9090AKB-9090 / HIF-PH / HIF-PH inhibitor / Kidney disease
Painful bumps, inflammation, abscesses, and flare-ups can make everyday life challenging
Disposition of drugs in cystic fibrosis